Frequent CD30 Expression in an Emerging Group of Mesenchymal Tumors With NTRK, BRAF, RAF1, or RET Fusions
Naoki Kojima, Taisuke Mori, Toru Motoi, Eisuke Kobayashi, Masayuki Yoshida, Yasushi Yatabe, Hitoshi Ichikawa, Akira Kawai, Kan Yonemori, Cristina R. Antonescu, Akihiko Yoshida
Topics & Concepts
PathologyCD34CD30ImmunohistochemistryAnaplastic lymphoma kinaseMesenchymal stem cellBiologyCancer researchMedicineStem cellLung cancerGeneticsMalignant pleural effusionSarcoma Diagnosis and TreatmentEar and Head TumorsNeurofibromatosis and Schwannoma Cases